Spyre Therapeutics Inc

SYRE

Equity

ISIN null / Valor 129513338

NASDAQ (2026-03-06)

USD 40.15-1.08%

Spyre Therapeutics Inc
UMushroom community rating:

3.74 7 votes No rating yet

NegativeNeutralPositive

About company

Spyre Therapeutics Inc is a biotechnology company focused on developing innovative treatments for immune-mediated diseases, particularly Inflammatory Bowel Disease (IBD). The company is engaged in the creation of advanced antibodies and therapeutic combinations, leveraging precision immunology to enhance treatment efficacy and patient convenience. By concentrating on these areas, Spyre Therapeutics aims to address significant unmet medical needs in the field of immunology, offering potential breakthroughs in the management of complex immune disorders.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

95.9%1Y

302%3Y

-77.8%5Y

Performance

69.5%1Y

116%3Y

126%5Y

Volatility

3153 M

Market cap (USD)

567,557

Daily traded volume (Shares)

23.35 / 22.37

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.74

7 votes

Performance:

3.00

Innovation:

3.26

Society:

3.52

Nature:

3.13

Mehmet John Evans

United Kingdom, 08 Nov 2025

good

Antonio Tramacere

United Kingdom, 07 Nov 2025

Under valued stock

Elsa Mhangami

United Kingdom, 05 Nov 2025

Spyre Therapeutics is a compelling innovation play with possibly high upside if its pipeline succeeds, but the risk is significant and the fundamentals (revenue, profitability, commercial track record) are not yet established.

EQUITIES OF THE SAME SECTOR

Axon Enterprise Inc

Axon Enterprise Inc Valor: 36372319

Annual Return

-50%0%+50%

Risk level

110

0.62%USD 574.01

Sarepta Therapeutics Inc

Sarepta Therapeutics Inc Valor: 19028527

Annual Return

-50%0%+50%

Risk level

110

2.96%USD 16.71

Netscout Systems Inc

Netscout Systems Inc Valor: 847783

Annual Return

-50%0%+50%

Risk level

110

-0.86%USD 29.80

Extreme Networks Inc

Extreme Networks Inc Valor: 653096

Annual Return

-50%0%+50%

Risk level

110

-3.19%USD 13.98

Vicor Corp

Vicor Corp Valor: 983399

Annual Return

-50%0%+50%

Risk level

110

-10.58%USD 162.67

Silicon Motion Technology Corporation

Silicon Motion Technology Corporation Valor: 2194973

Annual Return

-50%0%+50%

Risk level

110

-4.37%USD 118.35

Gogo Inc

Gogo Inc Valor: 14665669

Annual Return

-50%0%+50%

Risk level

110

-2.24%USD 5.23

Agilysys Inc

Agilysys Inc Valor: 1680840

Annual Return

-50%0%+50%

Risk level

110

-2.87%USD 77.46

ZoomInfo Technologies Inc

ZoomInfo Technologies Inc Valor: 52926985

Annual Return

-50%0%+50%

Risk level

110

-0.46%USD 6.56

Okta Inc

Okta Inc Valor: 36082513

Annual Return

-50%0%+50%

Risk level

110

1.34%USD 80.72

Logos provided by Clearbit

Spyre Therapeutics Inc

SYRE

ISIN null / Valor 129513338

Spyre Therapeutics Inc UMushroom community rating:

Mehmet John Evans

Antonio Tramacere

Elsa Mhangami

Spyre Therapeutics Inc
UMushroom community rating: